Target of RNAIII activating protein(TRAP)
AssigneeThe Regents of the University of California
InventorsNaomi Balaban, Tzipora Goldkorn
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a protein isolated from S. aureus that is the target of RAP, called TRAP, which is characterized by a molecular weight of about 21 KDa, is capable of being phosphorylated by RAP, and comprises an amino acid sequence of SEQ ID NO:2. In addition, the present invention is directed towards an antibody immunoreactive with TRAP that is preferably a monoclonal antibody or a humanized antibody but may be a polyclonal antibody. The invention provides a method of treating S. aureus infection by administering such a TRAP-inhibiting agent. The invention also features methods for identifying compounds that inhibit TRAP activity and/or inhibit TRAP-RAP interaction.
Claims5
An isolated TRAP protein comprising an amino acid sequence of SEQ ID NO:2.
Dependencies are inferred from the claim text.